MyMD Pharmaceuticals announced that it received notice from Nasdaq on March 4 informing the company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on the Nasdaq Capital Market.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MYMD: